Citizens Financial Group Inc. (CFG)

Citizens Financial Group Inc. is trading close to its long-term averages after a flat stretch, and the setup is more about valuation than momentum. The stock sits 0.40% below its 50-day simple moving average and 0.46% below its 200-day, and the 50-day average is only 0.07% below the 200-day, so the trend reads as down but without much separation between the averages. Analysts remain constructive: 17 of 20 rate the stock Buy, and the median 12-month target is $76.00. The main question for investors is whether earnings growth, which analysts expect to continue, can lift the price back through the averages.

Wall Street remains firmly positive on Citizens Financial Group Inc. Of 20 analysts with a current rating, 17 rate the stock Buy, 3 rate it Hold and none rate it Sell. Three months ago 15 of 18 ratings were Buy, so the share of Buy ratings has risen slightly. In the latest round, on October 20, 2026, Citigroup kept its Buy rating, while Truist Securities kept its Hold and Stephens & Co. kept its Equal-Weight. Morgan Stanley and RBC Capital kept their Overweight and Outperform ratings on October 19, 2026, and Cantor Fitzgerald kept its Overweight rating on October 14, 2026. None of these actions was an upgrade or downgrade.

The stock has beaten EPS estimates in each of the last seven reports, with the October 16, 2026 report coming in at $1.41 against a $1.39 estimate, a beat of 1.44%. Across all seven reports EPS beat the estimate every time, yet the share price was lower in the first session after five of them and higher after two. For investors, that means beats alone have not translated into immediate gains; the market has been reacting to guidance and expectations more than to the headline figure. The share price fell 0.95% in the first session after the October 16, 2026 report, and it also fell after the July 16, 2026 report (down 2.70%) and the October 15, 2025 report (down 6.40%, the largest first-session move in that record).

At a trailing P/E of 13.10, the stock trades at a discount to peers; the sector median P/E is 16.5, so the multiple is 20.6% below it. The trailing dividend yield is 2.91%, on an annual dividend of $1.90 per share. The return on equity of 8.90% is below the sector median of 13.8%, which explains part of the discount: the stock is cheaper than peers, but it is also earning less on shareholders' capital. Revenue grew 12.08% in the latest quarter year on year, slightly faster than the sector median of 11.7%.

Insiders sold $10.5M of stock across three sales over the last 18 months and made no open-market purchases. Insider sales are often planned in advance or made to cover tax on vesting shares, so they are a weaker signal than open-market purchases would be.

The base case for the coming months is that the stock keeps trading in a narrow band around its 50-day and 200-day averages while earnings estimates do the work. Analysts expect EPS to rise 37.2% this fiscal year to $5.30 and 22.5% next year to $6.49, and revenue to grow 11.1% this year. The bearish case rests on the trend: a break below the 20-day EMA at $64.74 would put the 52-week low of $49.00 back in view as the next floor, and the 2025 pattern of sharp drops after reports shows that earnings days can hurt even when results beat. Analyst targets range from $65.00 to $87.00, so the lowest target sits at today's price.

Support sits first at the 20-day EMA of $64.74, the nearest level below the price and a short-term average that has been tracking the stock. Below it, the 52-week low of $49.00 is the deeper floor, the lowest price in the past year. Resistance starts at the 50-day SMA of $65.64, just above the price, followed by the 200-day SMA of $65.69. Both averages sit almost on top of each other, so a move through them would be a single test rather than two separate ones. The 52-week high of $75.33 is the next ceiling above that.